Doctor profile · Federal record
Dr. David Pohl, M.D.
Pulmonary Disease Physician (CMS: Pulmonary Disease) · Austin, TX
- NPI 1871502641
- Accepts Medicare
- MIPS 14.0 / 100 · 2023
- 47 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
711 W 38Th St Ste C1
Austin, TX 787051126
(512) 380-6699
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- October 18, 2007
- Year of graduation
- 1979 — 47 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Texas #F4384
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1871502641. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,616
Distinct HCPCS
7
Medicare allowed
$448,626
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99307 |
Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | 6,624 | 91 | $39 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 966 | 360 | $40 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 874 | 342 | $128 | |
94664 |
Evaluation of use of breathing device | 869 | 345 | $18 | |
94640 |
Inhalation treatment for airway obstruction or sputum production | 98 | 95 | $9 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 95 | 95 | $220 | |
J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 90 | 90 | $0 |
In context: peer comparison
Among 13 peers in Austin Pulmonary Disease Physician, average services per provider: 154. This provider delivers 62× the peer median.Open Payments
Industry payments received
All-time total
$847
Transactions
39
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 9 | $282.49 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 10 | $259.23 | |
| Genzyme Corporation | 12 | $167.10 | |
| GlaxoSmithKline, LLC. | 2 | $36.16 | |
| Electromed, INC. | 2 | $26.60 | |
| Mallinckrodt Hospital Products INC. | 1 | $23.90 | |
| Takeda Pharmaceuticals U.S.A., INC. | 1 | $18.32 | |
| Amgen INC. | 1 | $17.06 | |
| Baxter Healthcare | 1 | $16.09 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,641
Patients
1,051
Total drug cost
$1,052,865
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Montelukast Sodium | Generic | 934 | 222 | $11,922 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 663 | 129 | $521,425 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 569 | 200 | $24,125 |
| Prednisone | Generic | 303 | 137 | $1,515 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 220 | 48 | $115,291 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | Brand | 161 | 41 | $138,151 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 137 | 31 | $76,010 |
| Ventolin Hfa (Albuterol Sulfate) | Brand | 108 | 40 | $8,428 |
| Amoxicillin-Clavulanate Potass (Amoxicillin/Potassium Clav) | Brand | 89 | 62 | $802 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 85 | 16 | $45,488 |
Hospital affiliations
Frequently asked questions
What is Dr. David Pohl's medical specialty?
Dr. David Pohl practices Pulmonary Disease Physician in Austin, TX.
Where does Dr. David Pohl practice?
Dr. David Pohl practices at 711 W 38Th St Ste C1, Austin, TX 787051126. Office phone: 5123806699.
What is Dr. David Pohl's NPI?
Dr. David Pohl's National Provider Identifier (NPI) is 1871502641, issued by NPPES.
Does Dr. David Pohl accept Medicare assignment?
Yes. Dr. David Pohl accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Pohl commonly perform?
Top Medicare-reported procedures in 2023: Subsequent nursing facility care with straightforward level of medical decision making (HCPCS 99307); Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS 94060); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.